VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CNC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CNCCentene Corporation
$64.54$31.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCNCBalance Sheet

Centene Corporation (CNC) Balance Sheet

26Y historyFree accessUpdated daily

The company has improved its financial position, reducing the debt-to-equity ratio to 0.76 in 2026Q1 from a peak of 0.94 in 2025Q4.

CNC Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Total Current Assets44.99B35.99B38B40.76B30.13B28.5B23.39B20.32B12B8.7B8.37B3.6B3.03B1.8B1.37B940.01M656.82M616.13M666.34M446.34M451.82M272.61M224.29M110.3M93.09M102.05M46.72M
Cash & Short-Term Investments23.74B17.89B16.68B19.65B14.39B14.66B12.38B12.99B6.06B4.6B4.43B1.94B1.79B1.14B983.07M704.2M455.51M443.31M488.49M314.85M337.97M204.06M178.39M79.51M69.23M90.04M26.42M
Cash Only21.26B17.89B14.06B17.19B12.07B13.12B10.8B12.12B5.34B4.07B3.93B1.76B1.61B1.04B843.95M573.7M434.17M403.75M379.1M268.58M271.05M147.36M84.11M64.35M59.66M88.87M19.02M
Short-Term Investments2.48B02.62B2.46B2.32B1.54B1.58B863M722M531M505M176M177M102.13M139.12M130.5M21.35M39.55M109.39M46.27M66.92M56.7M94.28M15.16M9.57M1.17M7.4M
Accounts Receivable---------------------------
Days Sales Outstanding---------------------------
Inventory00000000000011M13.74M0000-92.53M000023.1M2.85M2.52M2.58M
Days Inventory Outstanding---------------------------
Other Current Assets1.82B01.6B5.57B2.46B1.6B1.32B1.09B784M687M715M390M252M231M172.3M78.36M65.07M69.37M85.32M52.19M22.19M24.44M14.43M10.49M16.66M4.98M4.75M
Total Non-Current Assets36.19B41.67B44.45B43.88B46.74B49.88B45.33B20.67B18.9B13.15B11.83B3.73B2.8B1.73B1.37B1.25B1.29B1.09B784.81M672.78M443.16M395.43M303.64M252.39M117.24M29.32M19.3M
Property, Plant & Equipment2.09B2.35B2.43B2.42B4.99B6.96B2.77B2.78B1.71B1.1B797M518M445M395M375.89M349.62M326.34M230.42M175.86M135.88M110.69M67.2M023.11M6.29M3.8M1.36M
Fixed Asset Turnover90.80x82.74x67.22x63.77x28.99x18.11x40.06x26.83x35.24x43.82x50.95x43.94x37.21x27.50x21.58x14.91x13.63x17.81x19.13x20.38x20.59x22.41x-33.31x73.31x86.03x162.76x
Goodwill10.84B10.84B17.56B17.56B18.81B19.77B18.65B6.86B7.01B4.75B4.71B842M751M348.43M256.29M281.98M278.05M224.59M163.38M141.03M135.88M157.28M101.63M13.07M000
Intangible Assets4.36B4.53B5.41B6.1B6.91B7.82B8.39B2.06B2.24B1.4B1.54B155M123M48.78M20.27M27.43M29.11M22.48M17.57M13.21M16.2M17.37M14.44M6.29M10.7M2.4M15.54M
Long-Term Investments74.45B20.88B17.43B16.29B14.68B14.04B12.85B7.72B6.86B5.31B4.54B1.93B1.28B791.9M614.72M506.14M618.64M545.63M332.41M317.04M145.42M123.66M116.79M184.81M105M23.51M24.28M
Other Non-Current Assets---------------------------
Total Assets81.17B77.66B82.44B84.64B76.87B78.38B68.72B40.99B30.9B21.86B20.2B7.34B5.84B3.53B2.74B2.19B1.94B1.7B1.45B1.12B894.98M668.03M527.93M362.69M210.33M131.37M66.02M
Asset Turnover2.42x2.51x1.98x1.82x1.88x1.61x1.62x1.82x1.95x2.21x2.01x3.10x2.84x3.08x2.96x2.38x2.29x2.41x2.32x2.47x2.55x2.25x1.90x2.12x2.19x2.49x3.35x
Asset Growth %-8.95%-5.8%-2.59%10.11%-1.92%14.05%67.63%32.66%41.39%8.21%175.2%25.71%65.42%28.73%25.17%12.68%14.19%17.31%29.67%25.04%33.97%26.54%45.56%72.44%60.11%98.99%-
Total Current Liabilities40.05B21.48B34.26B36.72B28.46B25.77B21.59B12.93B11.97B9.33B8.62B3.63B2.9B1.56B1.2B837.61M765.25M715.91M640.98M486.8M387.95M214.65M202.16M128.79M101.93M67.28M51.97M
Accounts Payable16.83B20.54B13.02B16.25B9.35B8.29B7.07B4B4.05B4.17B3.76B976M768M338M219.07M216.5M0000000007.71M0
Days Payables Outstanding---------------------------
Short-Term Debt63M196M110M119M82M267M97M88M38M4M4M5M5M3M3.37M3.23M2.82M646K255K971K971K0486K579K000
Deferred Revenue (Current)0--------------------------
Other Current Liabilities5.37B-50M18.31B18B16.75B14.24B12.23B7.47B6.83B4.29B3.93B2.3B1.72B1.14B972.28M607.99M645.09M20.68M31.01M25.5M33.82M14.35M3.96M3.67M10.75M58.56M51.97M
Current Ratio1.12x1.68x1.11x1.11x1.06x1.11x1.08x1.57x1.00x0.93x0.97x0.99x1.05x1.15x1.15x1.12x0.86x0.86x1.04x0.92x1.16x1.27x1.11x0.86x0.91x1.52x0.90x
Quick Ratio1.12x1.68x1.11x1.11x1.06x1.11x1.08x1.57x1.00x0.93x0.97x0.99x1.04x1.15x1.15x1.12x0.86x0.86x1.18x0.92x1.16x1.27x1.11x0.68x0.89x1.48x0.85x
Cash Conversion Cycle---------------------------
Total Non-Current Liabilities19.6B36.13B21.67B21.97B24.17B25.59B21.17B15.37B7.91B5.65B5.52B1.39B1.05B726.74M590.83M416.3M381.58M367.03M308.9M217.28M180.61M101.33M54.46M13.79M5.33M7.71M22.88M
Long-Term Debt16.31B17.97B18.42B17.71B17.94B18.57B16.68B13.64B6.65B4.7B4.65B1.22B888M665.7M535.48M348.34M327.82M307.08M264.64M206.41M174.65M92.45M46.97M7.62M004M
Capital Lease Obligations0--------------------------
Deferred Tax Liabilities0--------------------------
Other Non-Current Liabilities---------------------------
Total Liabilities59.65B57.6B55.94B58.69B52.63B51.35B42.76B28.3B19.88B14.98B14.14B5.01B3.95B2.29B1.79B1.25B1.15B1.08B949.88M704.08M568.56M315.98M256.62M142.58M107.26M67.28M74.85M
Total Debt16.37B18.78B19.43B18.88B21.33B22.66B18.32B14.51B6.69B4.7B4.66B1.22B879M669M538.85M351.58M330.64M307.73M264.89M207.38M175.62M92.45M47.46M8.2M004M
Net Debt-4.89B889M5.37B1.68B9.26B9.54B7.52B2.39B1.34B627M725M-539M-731M-369M-305.1M-222.12M-103.53M-96.02M-114.21M-61.21M-95.43M-54.91M-36.65M-56.15M-59.66M-88.87M-15.02M
Debt / Equity0.76x0.94x0.73x0.73x0.88x0.84x0.71x1.14x0.61x0.68x0.77x0.53x0.46x0.54x0.56x0.38x0.41x0.50x0.53x0.50x0.54x0.26x0.17x0.04x---
Debt / EBITDA-2.76x-4.40x4.47x7.76x7.27x4.22x5.99x3.42x3.01x3.02x1.50x1.59x1.94x3.10x1.34x1.58x1.69x1.59x2.50x-1.00x0.64x0.15x--0.53x
Net Debt / EBITDA0.83x-1.22x0.40x3.37x3.06x1.73x0.98x0.69x0.40x0.47x-0.66x-1.32x-1.07x-1.75x-0.85x-0.50x-0.53x-0.68x-0.74x--0.60x-0.49x-1.05x-1.75x-4.37x-1.99x
Interest Coverage-9.03x-9.46x7.06x5.96x3.95x3.73x4.81x5.33x4.99x5.45x6.35x17.21x14.06x10.98x7.15x10.27x9.58x9.43x9.19x5.10x-1.04x22.52x104.36x268.49x915.13x--
Total Equity21.5B20.06B26.51B25.96B24.24B27.02B25.96B12.69B11.02B6.88B6.05B2.32B1.89B1.24B953.77M936.42M797.05M619.43M501.27M415.05M326.42M352.05M271.31M220.12M102.18M64.09M-8.83M
Equity Growth %-70.62%-24.35%2.13%7.09%-10.31%4.08%104.55%15.14%60.31%13.58%160.5%22.9%52.13%30.33%1.85%17.48%28.68%23.57%20.77%27.15%-7.28%29.76%23.26%115.41%59.44%825.48%-
Book Value per Share43.3940.8450.6247.5641.6445.7644.8330.1927.6619.4718.469.447.865.524.444.463.953.492.822.311.891.951.561.430.730.67-0.11
Total Shareholders' Equity21.43B19.95B26.41B25.84B24.06B26.8B25.77B12.55B10.92B6.85B5.89B2.16B1.74B1.23B953.06M935.63M793.94M600.85M501.27M415.05M326.42M352.05M271.31M220.12M102.18M64.09M-8.83M
Common Stock1M1M1M1M1M1M1M004.35B00059K55K54K52K46K43K44K44K43K41K20K11K10K0
Retained Earnings10.21B8.67B15.35B12.04B9.34B8.14B6.79B4.98B3.66B2.75B1.92B1.36B1B731.92M566.82M564.96M453.74M358.91M275.24M191.74M118.29M161.92M106.29M61.98M28.71M3.09M-9.29M
Treasury Stock-9.44B-9.44B-9B-5.86B-4.21B-1.09B-816M-214M-139M-244M-179M-147M-98M-89M-69.86M-57.12M-50.49M-47.26M-41M00000000
Accumulated OCI-171M-58M-504M-652M-1.13B77M337M134M-56M-3M-36M-10M-1M-2.62M5.19M5.76M6.42M7.35M3.15M0-1.25M-1.75M0740K1.09M135K81K
Minority Interest75M103M100M116M180M227M189M141M106M26M159M167M147M9M711K785K3.12M18.58M000000881K00

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Regulatory and medical trend volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Stabilization Following Restructuring

As reported in recent financial statements, Centene's total assets reached $81.2 billion in 2026Q1, reflecting a stabilization of the balance sheet after the significant asset volatility and divestiture-related fluctuations observed throughout the 2025 fiscal year as the company executed its Value Creation Plan.

The recent stabilization in total assets suggests that the company's strategic narrowing of its portfolio is beginning to yield a more predictable capital base. Investors should monitor whether this trend persists, as the reduction in asset volatility is a necessary precursor to restoring consistent long-term shareholder value.

Leverage Management Amidst Strategic Pivot

According to the latest quarterly filings, Centene's debt-to-equity ratio improved to 0.76 in 2026Q1, down from the 0.94 peak observed in 2025Q4, indicating a concerted effort by management to deleverage the balance sheet while navigating ongoing operational restructuring and market-wide medical cost pressures.

The reduction in leverage appears to be a deliberate move to improve financial flexibility in a high-interest-rate environment. While the current debt levels remain manageable, the company's reliance on government-sponsored revenue streams necessitates a conservative approach to debt to ensure resilience against potential state-level contract re-procurement risks.

Enhanced Cash Position Bolsters Resilience

Based on the provided balance sheet data, Centene's cash and equivalents surged to $21.3 billion in 2026Q1, representing a significant liquidity buffer that provides the company with substantial protection against the inherent volatility of government-sponsored healthcare payment cycles and potential medical loss ratio spikes.

This robust cash position suggests that the company is prioritizing liquidity to navigate the uncertainty of Medicaid redeterminations and potential regulatory shifts. Such a large cash pile may also provide the optionality needed to pursue strategic investments or further debt reduction if market conditions deteriorate.

Equity Quality Impacted by Impairments

As indicated by the reported figures, Centene's equity base experienced significant fluctuations, dropping from $27.9 billion in 2025Q1 to $21.4 billion in 2026Q1, largely driven by the accounting impact of divestitures and restructuring charges associated with the company's ongoing Value Creation Plan.

The contraction in equity highlights the tangible cost of the company's strategic pivot away from non-core assets. While these actions may improve long-term operational focus, the resulting impact on book value warrants careful investigation into whether the remaining asset base can generate sufficient returns on equity to satisfy investor expectations.

Goodwill and Intangible Asset Risks

Based on historical balance sheet data, Centene's goodwill and intangible assets, which stood at $10.8 billion in 2026Q1, represent a significant portion of the company's equity, posing a potential risk of future impairment charges if the acquired businesses fail to meet long-term performance targets.

The reduction in goodwill from $17.6 billion in 2025Q2 suggests that recent divestitures have successfully purged some of the acquisition-related bloat. However, the remaining balance remains a critical area for investors to monitor, as any further deterioration in the performance of core segments could necessitate additional write-downs.

CNC — Frequently Asked Questions

Quick answers to the most common questions about buying CNC stock.

What are the total assets of Centene Corporation (CNC)?

As of 2025, Centene Corporation (CNC) had total assets of $77.66B including $35.99B in current assets.

How much debt does Centene Corporation (CNC) have?

Centene Corporation (CNC) carries total debt of $18.78B, offset by $17.89B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Centene Corporation?

Centene Corporation (CNC) has total shareholders' equity (book value) of $19.95B ($40.84 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Centene Corporation's current ratio and liquidity?

Centene Corporation (CNC) reported a current ratio of 1.68x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.